Apeldoorn, Netherlands · Founded 2018 · Privately Held (backing)
Developer of therapies intended to treat cancer and improve the effectiveness of existing chemotherapy. Pleco Therapeutics is based in Apeldoorn, Netherlands and was founded in 2018. Its last reported valuation was $25.2 million in Sep 2022. It has raised $31.1 million.
Last reported valuation
$25.2M
Oct 2026
Priced at
—
Total raised
$31.1M
Last round
—
Cap table — not yet on record
Pleco Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Pleco Therapeutics with a free account
·Watch Pleco Therapeutics: the Monday email on marks, rounds and moves
